Neurosurgeon Harish Babu, MD, PhD, is the director of minimally invasive neurosurgery and an associate professor of neurosurgery at Upstate.
Unique trial aims to control seizures using regenerative human cell therapy
Some epilepsy patients at Upstate are eligible for a unique trial using regenerative human cell therapy to control seizures. Neurosurgeon Harish Babu, MD, PhD, who administered the first dose of this treatment at Upstate, explains the trial, its goal of helping patients with uncontrolled seizures and how it is the first time this therapy has been tried in humans to treat epilepsy.
